Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health
- PMID: 32773345
- DOI: 10.1016/j.jsxm.2020.07.006
Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health
Abstract
Background: In the last decade, many novel minimally invasive surgical techniques within benign prostatic hyperplasia (BPH) surgery were developed to reduce postoperative complications that often discourage patients from pursuing BPH surgery.
Aim: To assess perspective of future and past international BPH surgery patients regarding their postoperative complications, namely erectile and ejaculatory function.
Methods: A survey was distributed randomly to 2 groups of BPH patients: one with 149 patients having undergone surgery in the last 2 years (group A), and the other cohort of 151 men seriously considering BPH surgery in the next year (group B). This survey consisted of 20 questions that assessed patients' motivating factors for undergoing elective BPH surgery and their perspectives regarding the potential postoperative complications attributed to BPH surgery.
Outcomes: The perspective of future and past international BPH surgical patients towards the preservation of their erectile and ejaculatory functions was assessed with the help of a survey.
Results: Results indicated that in general BPH surgery patients considered the maintenance of erectile (95%, n = 284) and ejaculatory function (92%, n = 276) to be important preoperative considerations, regardless of their age. Patients aged 50-59 years were most concerned with the permanent impact on sexual function and patients aged >60 years were most concerned with urinary incontinence. In patients aged >70 years, 66% (n = 43) and 62% (n = 40) of the respondents indicated that maintaining erectile and ejaculatory function was important, respectively.
Clinical implications: Patient-centered care needs to be implemented in order to address the importance that past and future BPH surgery patients hold toward the maintenance of their postoperative sexual function.
Strengths & limitations: In the group of patients having previously undergone BPH surgery, the possibility of recall bias should be taken into account when interpreting the study's findings. However, maintaining sexual function was also important for the group of patients seriously considering surgery in the next year suggesting that these considerations are not solely due to recall bias. Additionally, the results were limited by the small sample size of participants in groups A (n = 149) and B (n = 151).
Conclusion: It was found that past and future BPH surgery patients attribute a significant importance toward the maintenance of their sexual function. Although novel approaches with better sexual outcomes such as Rezum and UroLift for prostates <80 mL, and Aquablation for any size prostate are available, more research is needed to investigate their long-term effects on sexual function before they can be recommended to patients. Bouhadana D, Nguyen D-D, Zorn KC, et al. Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health. J Sex Med 2020;17:2108-2112.
Keywords: BPH Surgery; Male Sexual Health; Minimally Invasive Surgical Techniques; Patient-Centered Care.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
Benign Prostatic Hyperplasia.J Urol. 2021 Aug;206(2):447-450. doi: 10.1097/JU.0000000000001854. Epub 2021 May 14. J Urol. 2021. PMID: 33985341 No abstract available.
Similar articles
-
Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Cochrane Database Syst Rev. 2019 Feb 13;2(2):CD013143. doi: 10.1002/14651858.CD013143.pub2. Cochrane Database Syst Rev. 2019. PMID: 30759311 Free PMC article.
-
Review of Sexual Preservation After Novel Benign Prostatic Hyperplasia Surgical Treatment Modalities From Food and Drug Administration Clinical Trials.Sex Med Rev. 2021 Jan;9(1):169-173. doi: 10.1016/j.sxmr.2020.09.003. Epub 2020 Dec 9. Sex Med Rev. 2021. PMID: 33309271 Review.
-
Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?J Sex Med. 2018 Dec;15(12):1728-1738. doi: 10.1016/j.jsxm.2018.10.006. Epub 2018 Nov 13. J Sex Med. 2018. PMID: 30446471 Clinical Trial.
-
A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia: Impact on erectile and ejaculatory domains.Investig Clin Urol. 2021 Mar;62(2):148-158. doi: 10.4111/icu.20200392. Investig Clin Urol. 2021. PMID: 33660441 Free PMC article. Review.
-
Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.J Sex Med. 2016 Jun;13(6):924-33. doi: 10.1016/j.jsxm.2016.03.372. Epub 2016 Apr 27. J Sex Med. 2016. PMID: 27129767 Clinical Trial.
Cited by
-
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.J Clin Med. 2022 Jun 22;11(13):3615. doi: 10.3390/jcm11133615. J Clin Med. 2022. PMID: 35806900 Free PMC article.
-
Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health.Curr Urol Rep. 2025 Jun 9;26(1):49. doi: 10.1007/s11934-025-01279-z. Curr Urol Rep. 2025. PMID: 40490610 Free PMC article. Review.
-
Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia.Qual Health Res. 2022 Nov;32(13):1979-1992. doi: 10.1177/10497323221129262. Epub 2022 Sep 26. Qual Health Res. 2022. PMID: 36154347 Free PMC article.
-
A narrative review of the management of benign prostatic hyperplasia in patients undergoing penile prosthesis surgery.Transl Androl Urol. 2021 Jun;10(6):2695-2704. doi: 10.21037/tau-20-1225. Transl Androl Urol. 2021. PMID: 34295754 Free PMC article. Review.
-
Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia A Canadian healthcare payer perspective.Can Urol Assoc J. 2023 Apr;17(4):103-110. doi: 10.5489/cuaj.8045. Can Urol Assoc J. 2023. PMID: 36486181 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous